S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

Ryan Specialty Stock Price, News & Analysis (NYSE:RYAN)

$45.04
-0.32 (-0.71%)
(As of 04:30 PM ET)
Compare
Today's Range
$44.82
$45.47
50-Day Range
$43.15
$49.09
52-Week Range
$35.10
$50.64
Volume
427,497 shs
Average Volume
663,610 shs
Market Capitalization
$11.72 billion
P/E Ratio
95.83
Dividend Yield
N/A
Price Target
$51.14

Ryan Specialty MarketRank™ Stock Analysis

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
13.5% Upside
$51.14 Price Target
Short Interest
Bearish
6.05% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.26mentions of Ryan Specialty in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$471,656 Sold Last Quarter
Proj. Earnings Growth
23.19%
From $1.38 to $1.70 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.33 out of 5 stars

Finance Sector

285th out of 777 stocks

Insurance Agents, Brokers, & Service Industry

6th out of 14 stocks


RYAN stock logo

About Ryan Specialty Stock (NYSE:RYAN)

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.

RYAN Stock Price History

RYAN Stock News Headlines

All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Ryan Specialty Completes Acquisition of AccuRisk Holdings
Ryan Specialty Holdings, Inc. (RYAN)
What 4 Analyst Ratings Have To Say About Ryan Specialty Hldgs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Ryan Specialty Group (RYAN) Meets Q3 Earnings Estimates
Ryan Specialty Reports Third Quarter 2023 Results
Ryan T. Johnson
Ryan Specialty to Acquire AccuRisk Holdings
AccuRisk Holdings to be Acquired by Ryan Specialty
See More Headlines
Receive RYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ryan Specialty and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Insurance agents, brokers, & service
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
3,850
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$51.14
High Stock Price Target
$59.00
Low Stock Price Target
$43.00
Potential Upside/Downside
+12.8%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$61.05 million
Pretax Margin
11.64%

Debt

Sales & Book Value

Annual Sales
$1.73 billion
Cash Flow
$1.69 per share
Book Value
$3.14 per share

Miscellaneous

Free Float
118,388,000
Market Cap
$11.80 billion
Optionable
Not Optionable
Beta
0.47
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives















RYAN Stock Analysis - Frequently Asked Questions

Should I buy or sell Ryan Specialty stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ryan Specialty in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RYAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYAN, but not buy additional shares or sell existing shares.
View RYAN analyst ratings
or view top-rated stocks.

What is Ryan Specialty's stock price target for 2024?

7 equities research analysts have issued twelve-month price targets for Ryan Specialty's stock. Their RYAN share price targets range from $43.00 to $59.00. On average, they expect the company's share price to reach $51.14 in the next twelve months. This suggests a possible upside of 13.5% from the stock's current price.
View analysts price targets for RYAN
or view top-rated stocks among Wall Street analysts.

How have RYAN shares performed in 2023?

Ryan Specialty's stock was trading at $41.51 at the beginning of the year. Since then, RYAN shares have increased by 8.6% and is now trading at $45.06.
View the best growth stocks for 2023 here
.

When is Ryan Specialty's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our RYAN earnings forecast
.

How were Ryan Specialty's earnings last quarter?

Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced its quarterly earnings results on Thursday, November, 2nd. The company reported $0.32 earnings per share for the quarter, meeting analysts' consensus estimates of $0.32. The firm had revenue of $501.94 million for the quarter, compared to analysts' expectations of $500.92 million. Ryan Specialty had a net margin of 9.18% and a trailing twelve-month return on equity of 42.39%.

What ETFs hold Ryan Specialty's stock?
When did Ryan Specialty IPO?

(RYAN) raised $1.3 billion in an IPO on Thursday, July 22nd 2021. The company issued 56,918,278 shares at $22.00-$25.00 per share.

Who are Ryan Specialty's major shareholders?

Ryan Specialty's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (3.92%), Artisan Partners Limited Partnership (1.09%), Blair William & Co. IL (1.02%), Morgan Stanley (0.81%), Victory Capital Management Inc. (0.69%) and American Century Companies Inc. (0.62%). Insiders that own company stock include Brendan Martin Mulshine, Corp Onex, David P Bolger, Lisa Jo Paschal-Alcorn, Mark Stephen Katz, Michael D Ohalleran, Michael Thomas Vanacker, Nicholas Dominic Cortezi, Patrick G Ryan and Timothy William Turner.
View institutional ownership trends
.

How do I buy shares of Ryan Specialty?

Shares of RYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:RYAN) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -